The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Avonex

30 microgram(s) Powder and solvent for solution for infusion

Biogen Idec LtdEU/1/97/033/002

Main Information

Trade NameAvonex
Active SubstancesInterferon beta - 1a
Strength30 microgram(s)
Dosage FormPowder and solvent for solution for infusion
Licence HolderBiogen Idec Ltd
Licence NumberEU/1/97/033/002

Group Information

ATC CodeL03AB Interferons
L03AB07 interferon beta-1a

Status

Authorised/WithdrawnAuthorised
Licence Issued22/01/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back